Early Coronavirus Drug Trials Yield Mixed Results
- HIV drug combination shows no benefit in severe patients
- Fujifilm medicine linked to materially faster viral clearance
This article is for subscribers only.
We’re tracking the latest on the coronavirus outbreak and the global response. Sign up here for our daily newsletter on what you need to know.
Drug trials on coronavirus patients in China yielded mixed results, with an HIV pill showing little benefit and a flu medication made by Fujifilm Holdings Corp. resulting in faster clearance of the virus.